Recently we have seen evidence of improved cancer control in high-risk patients treated with external beam radiotherapy with a brachytherapy boost to the prostate. This has been demonstrated with both HDR brachytherapy boost and with LDR brachytherapy boost. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, boost, radiation, stereotactic, therapy | 15 Comments »
This is the second part of a two-part commentary. In the first part, we looked at studies that identified the site of failure after primary radiation treatment, … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, radiation, salvagee, SBRT, stereotactic | 6 Comments »
Data reported at the recent Genitourinary Cancers Symposium have shown that the toxicities associated with stereotactic body radiation therapy (SBRT) are acceptable and similar whether the radiation is give as 5 or 12 doses. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionated, radiation, SBRT, stereotactic, toxicity | 2 Comments »
Katz and Kang will present their 9-year outcomes on 515 patients treated by stereotactic body radiation therapy (SBRT) at the Genitourinary Cancers Symposium tomorrow … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, outcome, radiation, SBRT, stereotactic | 6 Comments »
There are many details of stereotactic body radiation therapy (SBRT) that may be optimized over the coming years. Among them is the optimum treatment schedule — i.e., how far apart should the treatments be spaced? … READ MORE …
Filed under: Management, Treatment | Tagged: body, radiation, SBRT, side effect, stereotactic, toxicity | Leave a comment »
Treatments for high-risk prostate cancer are limited. Surgery is usually considered a poor option if the cancer has already escaped the prostate capsule (stage T3/4). External beam radiation is often given with hormone therapy for high grade cancers, or with a brachytherapy boost. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", ablative, body, radiation, SART, SBRT, stereotactic | Leave a comment »
Salvage or adjuvant external beam radiation therapy for prostate cancer is usually a protracted affair, more so since we learned that a total dose of about 64 Gy to 70 Gy was needed to be effective in the salvage setting. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, hypofractionation, post-surgical, radiation, salvage, standard, stereotactic, therapy | 6 Comments »
A group of Italian researchers has reported preliminary clinical experience of the use of stereotactic body radiation therapy (SBRT), using CyberKnife technology, in the treatment of isolated, nodal metastases as a consequence of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: CyberKnife, isolated, nodal, radiation, SBRT, stereotactic | 1 Comment »
A new article in Frontiers in Oncology now provides us with data from the median 6-year follow-up of > 450 men with prostate cancer treated with stereotactic body radiation therapy (SBRT) using the CyberKnife technology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, efficacy, outcome, radiation, SBRT, stereotactic | 6 Comments »
A new paper, published online today in the Journal of Clinical Oncology, suggests that stereotactic body radiation therapy (SBRT, commonly delivered using the CyberKnife system) has a higher risk for genitourinary (GU) toxicity than intensity-modulated radiation therapy (IMRT). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: radiation, risk, SBRT, side effect, stereotactic, toxicity | 10 Comments »
A paper in the May issue of the journal Radiation Oncology has provided 6-year outcome data (including quality of life and complications of treatment) after the use of stereotactic body radiation therapy (SBRT) using the CyberKnife system (from the Flushing Radiation Oncology group in Flushing, New York). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, localized, outcome, SBRT, stereotactic | 9 Comments »
A new paper in the journal Radiation Oncology provides data on a series of 41 men treated with stereotactic body radiation therapy for intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, CyberKnife, intermediate, radiatio, risk, SBRT, stereotactic | 2 Comments »
Data reported by Meier et al. and presented at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) provide some early guidance on the efficacy and safety of sterotactic body radiation therapy (SBRT) in treatment of men with intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: body, CyberKnife, intermediate risk, localized, radiation, SBRT, stereotactic | Leave a comment »
Data from a large, retrospective, multi-center study of stereotactic body radiation therapy (SBRT) with CyberKnife technology in the treatment of men with localized prostate cancer were presented on Wednesday afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, efficacy, outcome, radiation, SBRT, stereotactic, therapy | 1 Comment »
